Dendreon (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy. Its product PROVENGE (sipuleucel-T), a prescription medicine, is used to treat advanced prostate cancer.

Parent CompanySanpower Group
Dendreon was founded in 1992

Viewing summary data as a guest

Sign up for free to see all data

Dendreon Financials and Metrics

Summary Metrics

Founding Date

Dendreon is a subsidiary of Sanpower Group

Dendreon Online and Social Media Presence

Embed Graph

Dendreon Frequently Asked Questions

  • When was Dendreon founded?

    Dendreon was founded in 1992.

  • Who are Dendreon competitors?

    Competitors of Dendreon include Gradalis, WindMIL Therapeutics and Ectin Research.